Navigation Links
Genomas Awarded US Patent for its PhyzioGenomics Platform Technology to Predict Treatment Responses
Date:9/13/2010

HARTFORD, Conn., Sept. 13 /PRNewswire/ -- Genomas®, a biomedical company advancing DNA-Guided Medicine, has been awarded US Patent 7,747,392, entitled Physiogenomic Method for Predicting Clinical Outcomes of Treatment in Patients by the US Patent and Trademark Office.

Andreas Windemuth, Ph.D., Chief Technology Officer and co-inventor in the patent stated: "The PhyzioGenomics Technology has been successfully applied to several psychiatric and diabetes drugs and to brain imaging. The technology correlates genotypes and phenotypes in patient populations to discover clinically functional variability. The PhyzioGenomics Technology integrates a biomedical engineering systems approach with genome probes and nano-arrays."

Research on the PhyzioGenomics Technology has been published in the renowned journals Annals of Biomedical Engineering, Biomedical Engineering Handbook, Clinica Chimica Acta, Clinics in Laboratory Medicine, Molecular Psychiatry, Muscle & Nerve, Personalized Medicine, Pharmacogenomics, and Schizophrenia Research.

Gualberto Ruano, M.D., Ph.D., President of Genomas and co-inventor commented: "This fundamental patent covers also the configuration of our products and pipeline, the PhyzioTypeTM Systems. This is a landmark achievement for Genomas and allows us freedom to operate in our industry sector. In an otherwise crowded genomics landscape, and in the presence of an ever more stringent yardstick on novelty versus prior art, this patent significantly increases the value of our intellectual property portfolio and differentiates our proprietary PhyzioType products."

Filed in 2006, US Patent 7,747,392 comprises 23 methods claims and 384 polymorphic DNA sequences representative of 222 key cardiometabolic and neuroendocrine genes. Beyond this patent, the Intellectual Property portfolio of Genomas encompasses 5 patent applications, 2 trademarks, and a copyright on the company's clinical informatics system.

ABOUT GENOMAS

Genomas is a biomedical company advancing DNA-Guided Medicine and personalized healthcare. The company develops revolutionary PhyzioType™ Systems for DNA-guided management and prescription of drugs used to treat mental illness and diabetes. PhyzioType Systems provide physicians with an unprecedented capability to select for each patient the safest and most effective drug to achieve treatment goals and enhance patient compliance.

The company's clinical pharmacogenetic tests and consultation service are provided through its Laboratory of Personalized Health, an accredited and licensed high-complexity molecular diagnostic center and its Personalized Health Portal, a medical informatics interface for clinician decision support. Visit www.genomas.com for more information.


'/>"/>
SOURCE Genomas
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Genomas Awarded $1.4 Million NIH SBIR Grant to Develop MRI+DNA Guided Biomarker System for Mental Illness
2. Genomas and Institute of Living Among Organizers of Pharmacogenetics Symposium at 2009 Annual Meeting of the American Psychiatric Association
3. Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study
4. Genomas to Present at Life Sciences & Healthcare Venture Summit
5. Connecticut State Medical Society and Genomas Co-Sponsor Forum on DNA-Guided Medicine and the Path to Personalized Health Care
6. Elusys Awarded Additional $40.6 Million Under Existing U.S. Government Contract to Fund Advanced Development of Anthim, a New Treatment for Anthrax
7. Isolux Corsan Awarded a Contract for the Construction of an Ethanol Plant in Colombia
8. Laser pioneer Federico Capasso awarded Berthold Leibinger Zukunftspreis
9. San Diego Region Awarded $4 Million Workforce Development Grant to Support Expanding Biofuels Industry
10. Flad Architects Awarded Livermore Valley Open Campus Master Plan
11. Colorado State University student awarded top student prize in laser research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... on a range of subjects including policies, debt and investment ... Speaking at a lecture to the Canadian Economics ... the country,s inflation target, which is set by both the ... "In certain areas there needs to be frequent ... not sit down and address strategy together?" He ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):